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Three recent studies in C. elegans now outline a molecular system that protects the DNA of the germline. This system silences ''nonself'' DNA-such as transposons and pseudogenes-in a stably inherited manner while allowing the expression of ''self'' DNA. The system consists of three pathways, each requiring a member of the argonaute family that uses small RNA cofactors to guide sequencespecific binding to target sequences. One pathway recognizes foreign DNA and initiates silencing using the highly conserved Piwi Argonaute (PRG-1); a second pathway maintains silencing of foreign DNA using both argonaute proteins and chromatin factors; and the third pathway protects self DNA from silencing. Two of the studies were conducted by Craig Mello and colleagues and the third by Eric Miska and colleagues.
Each study took a different set of experimental approaches, but all relied on a recently developed technique to integrate a single copy of a transgene in the C. elegans genome. The researchers created worms containing single-copy transgenes containing foreign DNA sequences and observed that such transgenes were rapidly silenced-and that silencing was stably maintained through many generations. Genetic and biochemical analyses uncovered the factors required to initiate and maintain this silencing.
The findings show that silencing is initiated by PRG-1. PRG-1 is known to work with piwi-interacting RNAs (piRNAs)-21 nucleotide, genomically-encoded RNAs. More than 15 000 distinct piRNAs exist in C. elegans and as many as 200 000 piRNA species are expressed in the mammalian testes. The findings suggest that PRG-1 operates to broadly recognize foreign RNA, essentially ''scanning'' the genome for non-self sequences. This process does not require perfect base-pair matches between non-self RNA and piRNAs; indeed, the relaxed base-pairing facilitates whole-genome scanning by PRG-1.
After recognizing non-self RNA, PRG-1 initiates the formation of a second type of RNA (22G-RNA) that clusters onto the non-self sequence and works with argonaute proteins to help maintain silencing. Maintenance of silencing also seems to operate through epigenetic modification to DNA since it requires chromatin modifying factors such as methyltransferases.
Many genes were protected from silencing by PRG-1, even if they had sequences similar to piRNAs. The findings hint that these genes are protected by another argonaute protein, CSR-1. CSR-1 binds to small RNAs that are complementary to all of the expressed germline RNAs. The researchers speculate that these CSR-1-associated small RNAs provide a memory of self, although that remains to be shown.
The three studies uncover an elaborate and powerful system for maintaining the integrity of the DNA in the germline. The researchers speculate that their findings could also have evolutionary implications: perhaps the system could accelerate evolutionary change if it operated at heterozygous loci to silence one allele, thereby allowing phenotypic expression of recessive genes. Future studies are needed to determine whether a similar system exists in other phyla and species. Placental mammals have evolved complicated systems for reproduction and adaptive immunity. Sometimes these two systems can clash-pre-eclampsia, for instance, is a condition of inadequate placentation that may result from an overactive immune response during pregnancy. A variety of mechanisms have evolved to allow pregnancy, with its ''foreign'' fetus, to proceed in the midst of a hostile immune system. Reporting in Cell, Alexander Rudensky and colleagues have uncovered one such mechanism. They show that a gene regulatory element, unique to placental mammals, enables the production of immune-suppressing cells that shield the fetus from immune attack.
Regulatory T (Treg) cells, also called suppressor cells, quell the inflammatory immune response toward self and foreign antigens, protecting against overactive immunity. Treg cells fend off conditions such as asthma and autoimmunity and are known to operate during pregnancy to protect the fetus. Naturally occurring Tregs are produced in the thymus and likely mediate tolerance to self antigens. Adaptive or peripheral Tregs are produced throughout the body and then migrate to different locations where they seem to restrain immune responses to non-self antigens such as allergens and food. Both types of Tregs require the transcription factor Foxp3 for their development. Rudensky and colleagues previously found that the Foxp3 gene contains CNS1 (conserved noncoding sequence 1), a regulatory sequence required for the production of peripheral Tregs.
The researchers have now taken a close look at the role of CNS1 and peripheral Tregs in pregnancy. They found that peripheral Treg cells, recognizing fetal antigens derived from the father, accumulated in the decidua, the maternal portion of the placenta. These Treg cells require CNS1 for their development.
Pregnant female mice deficient in CNS1 had reduced numbers of Treg cells in the decidua, increased numbers of inflammatory immune cells, and high rates of fetal reabsorption. They also had defective remodeling of the spiral arteries. All these defects are features of preeclampsia.
CNS1 was present in all placental mammals examined, from elephants to dolphins and humans, but was not present in zebrafish or marsupials. Sequence analysis suggested that the enhancer element seems to have arisen as a retrotransposition event during the evolution of placental mammals. This finding dovetails with previous studies suggesting that many genes involved in placental development arise through retrotransposition.
The new findings suggest that it is the peripheral Tregs, not thymic Tregs, that protect the fetus during pregnancy. Together with previous data, these observations also suggest that retrotransposition may have driven both the evolution of the placenta and the evolution of a mechanism to protect the placenta from immune attack. After leaving the testis, sperm undergo a maturation process in the epididymis, where they are stored before being released during ejaculation. New findings suggest that while maturing in the epididymis, sperm harness a key factor, the tyrosine kinase cSrc, which is required for fertility in mice and therefore may be a target for contraception.
Dario Krapf and colleagues found that sperm from cSrc-null mice had severe motility defects and were unable to fertilize eggs in vitro, consistent with previous reports that these mice are sterile. The mice also had abnormal morphology of the epididymis and of a specific epithelial cell type, clear cells, which are primarily involved in acidification of the luminal fluid that bathes sperm and in the uptake of debris from the lumen.
cSrc was expressed in both clear cells and principal cells (another epithelial cell type) and seemed to be required for their proper function. In cSrc-null mice, these cells showed reduced expression of transporter proteins that regulate pH and fluid levels, which are carefully controlled during sperm maturation.
cSrc also seemed to be acquired by sperm as they mature and the kinase was enriched in the fluid of epididymosomes, the membranous structures that appear to deliver their contents to gametes by fusion with the sperm membrane.
The findings suggest that cSrc is involved in differentiation of epithelial cells in the epididymis and is also uploaded into sperm during epididymal maturation. Whether this process is conserved across mammalian reproduction remains to be determined. The DNA of single sperm has now been mapped and analyzed, revealing information about mutation, recombination, and other DNA alternations in the male germline.
Stephen Quake and colleagues pioneered the use of microfluidic devices for sequencing the DNA of single cells, and they have now applied their technology to human spermatozoa. They analyzed the DNA of 91 single sperm cells from a 40-year-old Caucasian man: Stephen Quake himself, who first publically revealed his genome in 2009 using a method he helped develop.
The researchers found rates of alterations to the genome that are compatible with previous studies that have been based on analyses of populations of individuals. In agreement with population data, the researchers found a recombination rate of approximately 23 events per cell. They report that about seven percent of the sperm had abnormal chromosome numbers, consistent with previous studies of a two to ten percent aneuploidy rate in sperm (in contrast with the 20 to 30 percent rate for oocytes). The rate of de novo mutation is consistent with evolutionary studies, which have shown that four to five times more mutations occur in the male than the female germline. Curiously, the number of de novo mutations varied substantially among the different sperm, suggesting that the rate of mutation may vary among cells in a single individual.
The researchers also found evidence for gene conversion, in which an allele acquires the sequence of its homolog without reciprocal recombination-possibly through a mechanism involving DNA repair. The findings also support the notion that various recombination hot spots might be favored by different individuals, since recombination in Quake's genome occurred preferentially in certain sites and not in others.
Comparing the results from this individual with others in the future will reveal deeper insight into human mutation, variation, and evolution.
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